000 01363 a2200397 4500
005 20250516052658.0
264 0 _c20120126
008 201201s 0 0 eng d
022 _a1536-3694
024 7 _a10.1097/FTD.0b013e3182281975
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarnes, Allan J
245 0 0 _aMDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.
_h[electronic resource]
260 _bTherapeutic drug monitoring
_cOct 2011
300 _a602-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aCross-Over Studies
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aN-Methyl-3,4-methylenedioxyamphetamine
_xadministration & dosage
650 0 4 _aSaliva
_xchemistry
650 0 4 _aYoung Adult
700 1 _aScheidweiler, Karl B
700 1 _aKolbrich-Spargo, Erin A
700 1 _aGorelick, David A
700 1 _aGoodwin, Robert S
700 1 _aHuestis, Marilyn A
773 0 _tTherapeutic drug monitoring
_gvol. 33
_gno. 5
_gp. 602-8
856 4 0 _uhttps://doi.org/10.1097/FTD.0b013e3182281975
_zAvailable from publisher's website
999 _c21103403
_d21103403